Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 543

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

UK prospective diabetes study (UKPDS): VIII. Study design, progress and performance

Open access
UK Prospective Diabetes Study Group·1991·Diabetologia
DOI 10.1007/bf00400195
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00400195

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 80

  1. Zimmet P (1982) Type 2 (non-insulin dependent) diabetes: an epidemiological overview. Diabetologia 22: 399?411 · DOI · Paper page
  2. Mather HM, Keen H (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J 291: 1081?1084 · DOI · Paper page
  3. Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105?111 · DOI · Paper page
  4. Panzram G (1987) Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123?131 · DOI · Paper page
  5. Panzram G, Zabel-Langhennig R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587?591 · DOI
  6. Laing W, Williams DRR (1989) Diabetes, a model for health care management. Office of Health Economics, London UK, No 92: 32?49
  7. Jarrett RJ, Keen H (1976) Hyperglycaemia and diabetes mellitus. Lancet II: 1009?1012 · DOI
  8. Pettitt DJ, Knowler WC, Lisse JR, Bennett PH (1980) Development of retinopathy and proteinuria in relation to plasma glucose concentration in Pima Indians. Lancet II: 1050?1052 · DOI
  9. Dornan TL, Mann JI, Turner RC (1982) Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 285: 1073?1077 · DOI
  10. McCance DR, Hadden DR, Atkinson AB, Archer DB, Kennedy L (1989) Long-term glycaemic control and diabetic retinopathy. Lancet II: 824?828 · DOI
  11. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T and the Steno Study Group (1985) Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 [Suppl 3]: 74?79 · DOI
  12. The Kroc Collaborative Study Group (1988) Diabetic retinopathy after two years of intensified insulin treatment. JAMA 260: 37?41 · DOI
  13. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of mean normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy; the Oslo Study. Br Med J 293: 1195?1199 · DOI · Paper page
  14. Bilous RW, Mauer SM, Sutherland DE, Najarian JS, Goetz FC, Steffes MW (1989) The effects of pancreas transplantation on the glomerular structure of renal allographs in patients with insulin-dependent diabetes. N Engl J Med 321: 80?85 · DOI · Paper page
  15. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS (1990) Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322: 1031?1037 · DOI · Paper page
  16. Holman RR, Turner RC (1977) Diabetes: the quest for basal normoglycaemia. Lancet I: 469?474 · DOI
  17. WHO Study Group (1985) Diabetes mellitus. World Health Organisation Technical Report Series No 727. WHO, Geneva
  18. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet I: 1373?1376 · DOI · Paper page
  19. Stamler R, Stamler J (1979) Asymptomatic hyperglycaemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations. J Chron Dis 32: 683?837 · DOI
  20. Fontbonne A, Charles MA, Thibult N et al. (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15 year followup. Diabetologia 34: 356?361 · DOI · Paper page
  21. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595?1607 · DOI · Paper page
  22. Fontbonne A, Eschwège E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300?304 · DOI · Paper page
  23. University Group Diabetic Program (1970) A study of the effects of hypoglycaemic agents on vascular complications on patients with adult-onset diabetes II. Mortality results. Diabetes 19 [Suppl 2]: 789?830
  24. Keen H, Jarrett RJ, Fuller J (1973) Tolbutamide and arterial disease in borderline diabetics. Excerpta Medica Int Congress Series 312: 588?602
  25. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G (1980) Ten-year follow-up of subjects with impaired glucose tolerance. Prevention of diabetes by tolbutamide and diet regulation. Diabetes 29: 41?49 · DOI · Paper page
  26. The DCCT Research Group (1986) The diabetes control and complications trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35: 530?544 · DOI · Paper page
  27. Hermann LS (1979) Metformin: a review of its pharmacological properties and therapeutic use. Diab Metab Rev 5: 233?245
  28. Standl E, Stiegler H, Roth R, Schulz K, Lehmacher W (1989) On the impact of hypertension on the prognosis of NIDDM. Results of the Schwabing GP-Program. Diab Metab 15: 352?358
  29. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Br Med J 291: 97?104 · DOI · Paper page
  30. Australian National Blood Pressure Study Management Committee (1980) The Australian Therapeutic trial in mild hypertension. Lancet I: 1261?1267
  31. Collins R, Peto R, MacMahon S et al. (1990) Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827?838 · DOI · Paper page
  32. Chobanian AV (1986) Antihypertensive therapy in evolution. N Engl J Med 314: 1701?1702 · doi:10.1056/nejm198606263142608
  33. Christensen CK, Mogensen CE (1987) Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diab Compl 1: 45?52
  34. Mogensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685?688 · DOI · Paper page
  35. Parving H-H, Anderson AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br J Med 294: 1443?1447 · DOI · Paper page
  36. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884?886 · DOI
  37. Wilkstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G (1988) Primary prevention with metoprolol in patients with hypertension. JAMA 259: 1976?1982 · doi:10.1001/jama.1988.03720130040027
  38. Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielsen MD, Giese J (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467?470 · DOI · Paper page
  39. Parving HH, Hommel E, Damkjær Nielsen M, Giese J (1989) Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 299: 533?536 · DOI
  40. Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375?378 · DOI · Paper page
  41. Zatz R, Rentz Dunn B, Meyer TW, Anderson S, Rennke HG, Brennen BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925?1930 · DOI · Paper page
  42. Dzau VJ (1988) Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77 [Suppl 1]: 4?13
  43. Dzau VJ (1986) Significance of the vascular renin-angiotensin pathway. Hypertension 8: 553?559 · DOI · Paper page
  44. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450?456 · DOI · Paper page
  45. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Ranagh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098?1104 · DOI · Paper page
  46. Deau VJ (1991) Renin and myocardial infarction in hypertension. N Engl J Med 324: 1128?1130
  47. Abert G, Ferrer P (1990) Effects of captopil on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharm 15: S65-S72 · DOI
  48. Powell JS, Clozel JP, Muller RKM et al. (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186?188 · DOI · Paper page
  49. Sawicki PT, Mühlhauser I, Baba T, Berger M (1990) Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia 33: 121?124 · doi:10.1007/bf00401052
  50. United Kingdom Prospective Diabetes Study (1985) III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 7 [Suppl 2]: 8?13
  51. United Kingdom Prospective Diabetes Study (1983) I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia 24: 404?411
  52. Holman RR, Turner RC (1978) Basal normoglycaemia attained with chlorpropamide in mild diabetes. Metabolism 27: 539?547 · DOI
  53. Holman RR, Steemson J, Darling P, Reeves WG, Turner RC (1984) Human ultralente insulin. Br Med J 288: 665?668 · DOI
  54. Metropolitan Life Insurance Company (1959) New weight standard for men and women. Stat Bull Metropolitan Life 40: 1?4
  55. Holman RR, Turner RC (1985) A practical guide to basal and prandial insulin therapy. Diab Med 2: 45?53 · DOI
  56. Phillips M, Simpson RW, Holman RR, Turner RC (1979) A simple and rational twice daily subcutaneous insulin regime. Distinction between basal and meal insulin requirement. Quart J Med 48: 493?506
  57. Turner RC, Holman RR, Matthews DR (1988) Sulphonylurea failure and inadequacy. In: Cameron D, Colagiuri S, Heding L (eds) Excerpta Medica, Amsterdam. Novo Symposium, Hamilton Island, pp 52?56
  58. United Kingdom Prospective Diabetes Study (1988) IV. Characteristics of newly-presenting type 2 diabetic patients: male preponderance and obesity at different ages. Diab Med 5: 154?159 · DOI
  59. United Kingdom Prospective Diabetes Study (1990) VI. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diab Res 13: 1?11
  60. Wright BM, Dore CF (1970) A random-zero sphygmomanometer. Lancet I: 33?35
  61. Ferris FL, Kassoff A, Bresnick GH, Bailey I (1982) New visual charts for clinical research. Am J Ophthalmol 94: 91?96 · DOI · Paper page
  62. Davis MD, Hubbard LD, Tarutmann J (1985) Studies of retinopathy; methodology assessment and classification with fundus photographs. Diabetes 35 [Suppl]: 42?49 · DOI
  63. Bloom S, Till S, Sonksen P, Smith S (1984) Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br J Med 288: 1793?1795 · DOI · Paper page
  64. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF (1981) Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 21: 18?24 · DOI · Paper page
  65. Ewing DJ, Campbell IW, Murray A, Neilson JMM, Clarke BF (1978) Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J 1: 145?147 · DOI · Paper page
  66. Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods, 2nd edn. World Health Organisation, Geneva
  67. Wahlefeld AW (1974) Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer M (ed) Methods of enzymatic analysis, 2nd edn, Vol.4. Verlag Chemie, Weinheim and Academic Press, New York London, pp 1831?1835 · DOI · Paper page
  68. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19: 838?839
  69. Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583?594 · DOI · Paper page
  70. Moore JC, Morris JE (1982) A simple automated colorimetric method for determination of N-acetyl-B-D-glucosaminidase. Ann Clin Biochem 19: 157?159 · DOI
  71. Albano JM, Ekins RP, Maritz G, Turner RC (1972) A sensitive precise radio-immunoassay of human insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487?509 · DOI · Paper page
  72. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN (1987) Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J Clin Path 40: 465?468 · DOI
  73. Henry RJ, Cannon DC, Winkelman JW (1974) Clinical chemistry; principles and technics. Harper & Row, Hagerstown, pp 552?553
  74. Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543?1546 · DOI · Paper page
  75. Yuen CT, Kind PRN, Price RG, Praill PFG, Richardson AC (1984) Colorimetric assay for N-acetyl-beta-D-glucosaminidase (NAG) in pathological urine using the omega W-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann Clin Biochem 21: 295?300 · doi:10.1177/000456328402100411
  76. Westgard JO, Barry PL, Hunt MR (1981) A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 27: 493?501 · DOI · Paper page
  77. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmus U, Murrells TJ (1984) Microalbuminuria predicts mortality in noninsulin-dependent diabetes. Diab Med 1: 17?19 · DOI · Paper page
  78. Mogensen CE (1986) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356?360 · DOI · Paper page
  79. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diab Med 5: 126?134 · DOI · Paper page
  80. Stratton IM, Holman RR, Oakes SM, Turner RC for UK Prospective Diabetes Study Group (1991) Randomised trial of tight blood pressure control with ACE inhibitor or B-blocker compared with less tight control in Type II diabetic patients. Diabetes 40 [Suppl 1]: 369 (Abstract)

Cited by

See all 543

Metadata

Authors
UK Prospective Diabetes Study Group
Venue
Diabetologia
Publisher
Springer Science and Business Media LLC
Published
1991-12
Volume
34
Issue
12
Pages
877-890
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
DOI
10.1007/bf00400195
OpenAlex
W2944448728
Cited by
543
References
5
FWCI
7.34
Type
journal article
Language
en
Open access
bronze
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.